Bayer and Mitsui Chemicals Agro (MCAG) signed a license agreement for the development and marketing of quinofumelin (3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinoline), a new fungicide invented by MCAG. Under the terms of this agreement, MCAG has granted Bayer a worldwide exclusive right to develop and commercialize quinofumelin-based products for crop use, except in selected countries and regions including Japan where MCAG holds exclusive or shares co-exclusive rights with Bayer.

Intended use applications for the fungicide include fruit trees, leafy vegetables, fruiting vegetables, oilseed rape, and rice. The first registration application is planned for 2020 in Japan, followed by other countries.

• Bayer AG, Leverkusen, Germany
• Mitsui Chemicals Agro, Inc. (MCAG), Tokyo, Japan